webinar register page

Webinar banner
Improving ILD Diagnosis and Predicting Clinical Progression With the Envisia Genomic Classifier
In this webinar, speakers will discuss updated IPF/PPF guidelines, key utility data, and the role of the Envisia Genomic Classifier in ILD diagnosis and prognosis. New data will be presented that demonstrate how the Envisia Classifier can predict clinical progression in fibrotic interstitial lung disease.

Dec 6, 2022 02:00 PM in Central Time (US and Canada)

* Required information
Loading
All opinions expressed and information provided as part of this program are those of the presenters only. The content of this program has not been reviewed by CHEST and CHEST does not endorse or take any position regarding the contents, opinions or information associated with this program.

CHEST Privacy Policy

Speakers

William Bulman, MD
@Veracyte, Inc.
Medical Director
Sandeep Bansal, MD, FCCP, FACP
@Penn Highlands Healthcare
Medical Director, The Lung Center
Anna Podolanczuk, MD, MS
@Weill Cornell Medicine
Assistant Professor of Medicine Pulmonary & Critical Care Medicine